Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales
Go back to Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales| Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) | Delayed: 99.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.98 | 52 Week High | $2.68 | |||
| Open | $99.98 | 52 Week Low | $1.30 | |||
| Day High | $99.98 | P/E | N/A | |||
| Day Low | $99.98 | EPS | $-0.08 | |||
| Volume | 8,302 | |||||
| Orexigen Therapeutics, Inc. (NASDAQ: OREX) | Delayed: 0.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $4.75 | |||
| Open | $0.04 | 52 Week Low | $0.35 | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.22 | EPS | $-1.02 | |||
| Volume | 74,385 | |||||
| Vivus, Inc. (NASDAQ: VVUS) | Delayed: 0.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $1.85 | |||
| Open | $44.85 | 52 Week Low | $0.92 | |||
| Day High | $0.47 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $-2.13 | |||
| Volume | 1,328 | |||||
